Proactive Investors - Run By Investors For Investors

Aphria's Colombian subsidiary Colcanna partners with Colombian Medical Federation

A new academic curriculum will offer Colombia’s doctors and medical professionals a source of information on medical cannabis
South America
Aphria produces and sells medical cannabis in Canada and internationally

Aphria Inc (TSX:APHA) (NYSE:APHA) announced Wednesday that its Colombian subsidiary, Colcanna SAS is partnering with the Federación Médica Colombiana, a national guild that oversees the ethics of the medical profession in Colombia, to develop an academic curriculum on the medicinal use of cannabis.

The new guidance will offer Colombia’s doctors and medical professionals a credible source of information on medical cannabis. The Federación Médica Colombiana (FMC) has nearly 2,000 affiliated doctors as well as more than 70,000 medical professionals who access the organization's materials for research and education.

READ: Aphria reports higher 1Q fiscal first quarter revenue and looks ahead to cannabis legalization in Canada

The medical cannabis curriculum developed by Colcanna and FMC will be made accessible on FMC’s online platform which offers courses on a range of subjects.

“Education in the medical community is critical for sustaining the advancement of medical cannabis in Colombia,” said Gabriel Meneses, vice-president for Latin America and the Caribbean with Aphria in a statement.

Headquartered in Leamington, Ontario, Aphria produces and sells medical cannabis in Canada and internationally.

Aphria shares were down slightly in pre-market trading in New York on Wednesday, slipping by 0.7% to hit $5.65.

Contact Ellen Kelleher at [email protected]

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full APH profile View Profile

Aphria Timeline

Related Articles

medical cannabis
September 30 2018
The companies will collaborate on activities to develop cannabinoid medicines as a medical option in Chile.
cannabis extract
The Kelowna, BC-based cannabis company specializes in the research, development, production, and testing of high-quality cannabis extracts and oils
High Hampton Holdings set to add near term revenue to bottom line with Mojave Jane acquisition
November 12 2018
Mojave Jane is a California-licensed manufacturer of premium cannabis extracts and concentrates for buyers in the US state
Copyright ©, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use